Champions腫瘤 CSBR 深 滬
等待開盤 07-22 09:30:00 美东时间
8.03
+0.020
+0.25%
華盛通- 最 高8.36
- 今 開8.10
- 成交量 5.26万股
- 最 低 7.9901
- 昨 收 8.01
- 總市值 1.11亿
- 52周最高 11.99
- 市盈率 靜 --
- 換手率 0.38%
- 52周最低 3.6001
- 委 比 -66.67%
- 總股本 1382.69万
- 歷史最高 19.80
- 量 比 3.25
- 振 幅 4.62%
- 歷史最低 1.11
- 每 手 1
- 風險率 2.32%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards®
Derek Maetzold, founder and CEO of Castle Biosciences, was awarded the Gold-level Stevie® Lifetime Achievement Award for transformative leadership in healthcare, particularly in molecular diagnostics and precision medicine. The award recognizes his vision, scientific expertise, and commitment to improving patient care. Under his leadership, Castle Biosciences has grown into a industry leader, fundamentally changing clinical care. Judges highlight...
06-04 11:00
Rapid Micro Biosystems's Earnings Outlook
Rapid Micro Biosystems (NASDAQ:RPID) is preparing to release its quarterly earn...
05-09 01:02
美股大行评级 | 韦德布什：维持Astria Therapeutics(ATXS)"跑赢大市"评级，目标价从27美元升至28美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106863358302064640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 韦德布什：维持Astria Therapeutics(ATXS)"跑赢大市"评级，目标价从27美元升至28美元</p> <p>• HC Wainwright & Co.：维持LifeMD(LFMD)"买入"评级，目
03-13 09:38
Champions Oncology Achieves Record Revenue and Profit
Champions Oncology ( ($CSBR) ) has released its Q3 earnings. Here is a breakdow...
03-12 12:06
Here are top-rated defensive stocks as market rally sputters
Industries that typically hold up well during times of stock-market volatility – such as healthcare, consumer staples and utilities – may be worth another look as the rally sputters. U.S. stocks on Fr...
02-24 01:16
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
Shares of IMAC Holdings, Inc. (NASDAQ:BACK) rose sharply in today's pre-market ...
01-28 18:06
Momentum reigned 2024: Buy-rated U.S. stocks with the highest RSI
Momentum was the best trading factor group in 2024, up 19%, according to BofA Securities. Below are buy-rated U.S. stocks by SA Quant Metrics (with Quant ratings of at least 4.5) and the highest relat...
01-04 02:28
美股大行评级 | 潜在升幅233%，SenesTech目标价获上调至10美元
<span> <meta content="no-referrer" name="referrer"></span><img src="https://r.hstong.com/public/cms/images/2024/12/13/20241213084359656.png" referrerpolicy="no-referrer"><figure class="table" style="overflow-x: scroll;"> <table> <tbody> <tr> <td>标的</td> <td>代码</td> <td>评级</td> <td>目标价</td> <td>当前价</td> <td>潜在涨跌幅</td> <td>机构名称</td> </tr> <tr> <td>SenesTech</td> <td>SNES</td> <td>上调</td> <t
2024-12-13 08:44
Craig-Hallum Maintains Buy on Champions Oncology, Raises Price Target to $8
Craig-Hallum analyst Matt Hewitt maintains Champions Oncology (NASDAQ:CSBR) with a Buy and raises the price target from $6 to $8.
2024-12-13 00:23
Champions Oncology Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
2024-12-13 00:22
